Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REPLIGEN CORPRGEN · Entity 486 | Chief Operating Officer | March 05, 2026 | March 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REPLIGEN CORP
Report date March 05, 2026 · Filed March 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,423 |
Reported balance
After 2026-03-05 transaction · row 1
1 source rowRow 1 · 2026-03-05 · Grant · Acquired 7,751 · Balance 25,423 F1: Mr. Bylund was awarded 7,751 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $141.91 · Expires 2036-03-05 | Direct | 8,315 |
Reported balance
After 2026-03-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-05 · Grant · Acquired 8,315 · Balance 8,315 F2: One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Bylund was awarded 7,751 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2: One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2026 Filed Mar 23, 2026 15:53 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 8,315 | $0.00 Strike: $141.91 | $0.00 |
DisclosureSEC source: 0001193125-26-119034 · ownership.xml · derivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,315 Underlying: Common Stock · 8,315 shares Expires 2036-03-05 F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029. Read SEC document |
| March 05, 2026 Filed Mar 23, 2026 15:53 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 7,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-119034 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,423 F1 · shares: Mr. Bylund was awarded 7,751 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 18:28 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 62 | $125.84 | $7,802.08 |
DisclosureSEC source: 0001193125-26-093379 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,672 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 18:28 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-093379 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,734 F1 · shares: Represents 125 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2025. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 19:02 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 2,433 | $124.97 | $304,052.01 |
DisclosureSEC source: 0001193125-26-087669 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,609 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 19:02 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 1,478 | $128.73 | $190,262.94 |
DisclosureSEC source: 0001193125-26-087669 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,042 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 21:30 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,191 | $151.21 | $331,301.11 |
DisclosureSEC source: 0001193125-25-288160 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,520 F1 · price: $151.21 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.21 to $151.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 14:33 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 454 | $128.50 | $58,339.00 |
DisclosureSEC source: 0000950170-25-048942 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,711 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 13, 2025 Filed Mar 20, 2025 17:51 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 175 | $142.44 | $24,927.00 |
DisclosureSEC source: 0000950170-25-042471 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,165 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units. Read SEC document |
| March 13, 2025 Filed Mar 20, 2025 17:51 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 381 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-042471 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,340 F1 · shares: Represents 63 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on May 16, 2023, and 318 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on December 12, 2023. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:29 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 6,056 | $0.00 Strike: $155.38 | $0.00 |
DisclosureSEC source: 0000950170-25-031569 · ownership.xml · derivative · entry 3 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,056 Underlying: Common Stock · 6,056 shares Expires 2035-03-03 F3 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:29 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 1,239 | $155.38 | $192,515.82 |
DisclosureSEC source: 0000950170-25-031569 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,959 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 18:29 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 6,435 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031569 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,198 F1 · shares: Mr. Bylund was awarded 6,435 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:29 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 1,285 | $156.54 | $201,153.90 |
DisclosureSEC source: 0000950170-25-030066 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,763 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of performance stock units. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 15:27 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 543 | $164.74 | $89,453.82 |
DisclosureSEC source: 0000950170-25-026175 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,048 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of performance stock units. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 21:04 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 444 | $182.95 | $81,229.80 |
DisclosureSEC source: 0000950170-24-041891 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,591 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 21:23 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 1,206 | $195.72 | $236,038.32 |
DisclosureSEC source: 0000950170-24-027996 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,035 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 01:06 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 22 | $195.52 | $4,301.44 |
DisclosureSEC source: 0000950170-24-027504 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,241 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of performance stock units. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 01:06 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 197 | $193.99 | $38,216.03 |
DisclosureSEC source: 0000950170-24-027504 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,263 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of performance stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 02:45 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 820 | $191.79 | $157,267.80 |
DisclosureSEC source: 0000950170-24-025293 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,410 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:44 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026715 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,460 F1 · shares: Represents 50 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on May 16, 2023. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 404 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-025293 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,230 F1 · shares: Represents 404 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 24, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 02:25 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 8,632 | $0.00 Strike: $192.71 | $0.00 |
DisclosureSEC source: 0000950170-24-023495 · ownership.xml · derivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,632 Underlying: Common Stock · 8,632 shares Expires 2034-02-27 F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026 and February 27, 2027. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 02:25 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 8,691 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-023495 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,826 F1 · shares: Mr. Bylund was awarded 8,691 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 01:38 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 940 | $0.00 Strike: $94.33 | $0.00 |
DisclosureSEC source: 0000950170-24-020513 · ownership.xml · derivative · entry 3 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 940 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 2,000 shares vest and become exercisable on both 4/1/2024 and 4/1/2025. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 01:38 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 4,373 | $198.08 | $866,203.84 |
DisclosureSEC source: 0000950170-24-020513 · ownership.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,135 F1 · price: $198.08 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.73 to $198.46 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 01:38 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 940 | $94.33 | $88,670.20 |
DisclosureSEC source: 0000950170-24-020513 · ownership.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2023 Filed Apr 5, 2023 01:37 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 334 | $163.45 | $54,592.30 |
DisclosureSEC source: 0000899243-23-010599 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,568 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 22:13 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 210 | $188.00 | $39,480.00 |
DisclosureSEC source: 0000899243-23-007191 · doc4.xml · nonDerivative · entry 3 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,902 F3 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 22:13 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007191 · doc4.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,112 F2 · shares: Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:13 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 8,644 | $0.00 Strike: $180.48 | $0.00 |
DisclosureSEC source: 0000899243-23-007191 · doc4.xml · derivative · entry 4 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,644 Underlying: Common Stock · 8,644 shares Expires 2033-03-02 F4 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025 and March 2, 2026. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:13 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 8,348 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007191 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,487 F1 · shares: Mr. Bylund was awarded 8,348 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:54 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 594 | $173.44 | $103,023.36 |
DisclosureSEC source: 0000899243-23-006514 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,139 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:32 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $94.33 | $0.00 |
DisclosureSEC source: 0000899243-22-027710 · doc4.xml · derivative · entry 3 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 2,000 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 4,000 of the shares underlying the option have vested. The remaining shares vest as follows: 2,000 shares on April 1, 2023, April 1, 2024 and April 1, 2025. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:32 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,000 | $240.40 | $480,800.00 |
DisclosureSEC source: 0000899243-22-027710 · doc4.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,733 F1 · price: $240.40 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.36 to $240.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:32 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 2,000 | $94.33 | $188,660.00 |
DisclosureSEC source: 0000899243-22-027710 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:57 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 335 | $188.02 | $62,986.70 |
DisclosureSEC source: 0000899243-22-013421 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,733 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:07 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 4,312 | $0.00 Strike: $189.21 | $0.00 |
DisclosureSEC source: 0000899243-22-008174 · doc4.xml · derivative · entry 3 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,312 Underlying: Common Stock · 4,312 shares Expires 2032-02-24 F3 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 24, 2023, February 24, 2024 and February 24, 2025. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:07 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 188 | $189.21 | $35,571.48 |
DisclosureSEC source: 0000899243-22-008174 · doc4.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,068 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:07 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-008174 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,256 F1 · shares: Mr. Bylund was awarded 3,366 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:37 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 334 | $182.42 | $60,928.28 |
DisclosureSEC source: 0000899243-22-007259 · doc4.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,890 F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:37 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-007259 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,224 F1 · shares: Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 4, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 23:55 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 360 | $204.25 | $73,530.00 |
DisclosureSEC source: 0000899243-21-015429 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · SVP, Global Operations & IT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,324 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $204.25 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.07 to $204.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.